Akkermansia muciniphila: Gut Health & Metabolic Benefits

ByRohan Smith
The Benefits of Akkermansia muciniphila: Supporting Gut Health and Metabolic Function

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Akkermansia muciniphila is a mucin-degrading gut bacterium that may support intestinal barrier integrity, help regulate systemic inflammation, and improve metabolic markers including insulin sensitivity and glucose homeostasis. Research published in journals such as Nature Medicine and Gut has linked higher Akkermansia abundance with healthier weight and glucose markers, and a small 2019 human trial found pasteurised Akkermansia improved insulin sensitivity. Dietary diversity, polyphenol intake, and personalised microbiome testing may help support healthy levels of this bacterium.

At a Glance

  • Akkermansia muciniphila makes up about 0.5-5% of total gut bacteria and is one of the most abundant single species in the human gut.
  • Higher Akkermansia abundance has been linked with lower fasting glucose, lower triglycerides, and healthier body fat distribution in overweight and obese adults.
  • The Akkermansia outer membrane protein Amuc_1100 improved the gut barrier in mice, and vesicles the bacterium releases raised the tight junction protein occludin in lab-grown gut cells.
  • Cranberry, grape, and tea polyphenols raised Akkermansia in mouse studies, and human trials have reported increases with pomegranate extract, resveratrol, and inulin.
  • Lower Akkermansia levels have been reported in people with overweight, obesity, untreated type 2 diabetes, and inflammatory bowel disease (IBD).

Understanding Akkermansia muciniphila

Akkermansia muciniphila, first isolated and characterised by Professor Willem de Vos and Dr Muriel Derrien at Wageningen University in 2004, is a Gram-negative, anaerobic bacterium that resides in the mucus layer lining the intestinal wall. Unlike many gut microbes that rely on dietary fibre alone, Akkermansia feeds on mucin, a glycoprotein produced by goblet cells in the intestinal epithelium (1). It makes up about 0.5-5% of total gut bacteria (2).

Research published in journals including Nature Medicine, Gut, and PNAS has linked Akkermansia with inflammation regulation, gut barrier integrity, and metabolic balance (3-5). These functions sit within the broader context of the gut microbiome and its interaction with immune and metabolic systems. Learn more about gut health.

How Akkermansia Supports Gut Health

Anti-Inflammatory Activity

Akkermansia produces the short-chain fatty acids (SCFAs) propionate and acetate as it breaks down mucin (6). In a mouse model of colitis, giving the bacterium lowered inflammatory cytokines including interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) (7). Its outer membrane protein Amuc_1100 interacts with Toll-like receptor 2 (TLR2), and in lab work it mainly drove production of the anti-inflammatory cytokine IL-10 (8,9). Chronic low-grade inflammation has been linked to metabolic disorders, immune dysregulation, and gut barrier impairment, making this anti-inflammatory role clinically relevant. Persistent inflammatory signalling is also commonly observed in individuals with ongoing fatigue and post-viral illness, including chronic fatigue syndromes.

Maintenance of the Gut Mucus Layer

Akkermansia uses mucin as an energy source, yet in mice on a high-fat diet, treatment with live Akkermansia improved mucus layer thickness, while heat-killed cells did not (5). A healthy mucus layer helps protect the intestinal lining from pathogens and supports beneficial microbial interactions.

Improved Gut Barrier Integrity

In lab studies, Akkermansia strengthened the integrity of gut cell layers (10), and vesicles it releases raised expression of the tight junction protein occludin (11). In mice, Amuc_1100 also improved the gut barrier (8). This may help reduce intestinal permeability, limiting the translocation of lipopolysaccharide (LPS) and other inflammatory compounds into systemic circulation (5).

Metabolic and Cardiometabolic Associations

Human and animal studies, including the 2019 clinical trial by Depommier, Professor Patrice Cani and colleagues published in Nature Medicine, have linked Akkermansia with better metabolic markers. That trial was a small pilot, with 32 people completing it, and much of the mechanism work comes from mice.

Metabolic Marker What human studies found Proposed mechanism (mostly mouse data)
Insulin sensitivity Improved by about 29% against placebo with pasteurised Akkermansia (3). Greater improvement after calorie restriction in people with higher starting levels (4) Improved gut barrier and lower endotoxaemia (5)
Glucose regulation Higher levels linked with lower fasting glucose (4). Fasting glucose and HbA1c did not change in the 2019 trial, whose volunteers were not highly hyperglycaemic (3) GLP-1 secretion triggered by P9, a protein the bacterium secretes (12)
Lipid metabolism Higher levels linked with lower triglycerides (4). Total cholesterol fell about 9% in the 2019 trial; the falls in LDL and triglycerides were not significant (3) Reduced dyslipidaemia in mice given pasteurised Akkermansia (8)
Body composition Higher levels linked with lower waist-to-hip ratio and healthier fat distribution (4). Levels were lower in severe obesity than in moderate obesity (13) Less fat mass gain and adipose tissue inflammation (5)
Type 2 diabetes The bacterial class it belongs to was lower in prediabetes and newly diagnosed type 2 diabetes (14). Metformin is linked with higher levels, so medication can affect comparisons (15) Endocannabinoid signalling (5)

These effects appear to be mediated through gut barrier support, inflammation reduction, and microbial signalling pathways, including the endocannabinoid system, that influence host metabolism (5,8,12). The link does not hold in every group: in women with severe obesity, Akkermansia abundance was not associated with glucose markers before or after bariatric surgery (13). Lower levels have also been reported in inflammatory bowel disease (16).

Strategies to Support Akkermansia Levels

Dietary Diversity

A diverse, fibre-rich diet remains a foundational strategy for supporting overall microbial balance. For Akkermansia itself, a 2019 systematic review of human dietary trials reported increases with calorie restriction and with supplements including pomegranate extract, resveratrol, and inulin, and lower levels on a low-FODMAP diet. Some results were limited to subgroups, and the authors say more research is needed (17).

Food Category Examples What the evidence shows
Polyphenol-rich foods Cranberries, grapes, green tea, pomegranate Cranberry extract, grape polyphenols, and tea polyphenols raised Akkermansia in mice (18-20). Pomegranate extract and resveratrol were linked with increases in human trials (17)
Prebiotic fibres Inulin, fructo-oligosaccharides (FOS), chicory root Prebiotic feeding restored Akkermansia in obese and diabetic mice (5). Inulin was linked with increases in human trials (17)
Fermented foods Kefir, sauerkraut, kimchi A high-fermented-food diet raised overall microbial diversity and lowered inflammatory markers in a 17-week human trial (21). This finding is not specific to Akkermansia
Omega-3 rich foods Fatty fish Mice fed fish oil had more Akkermansia than mice fed lard (22)

Lifestyle Factors

Physical activity has been linked with higher levels: women active to at least the level the World Health Organization recommends had more Akkermansia than sedentary women (23). Adequate sleep and stress management support overall health, although direct human evidence tying them to Akkermansia levels is limited.

Personalised Approaches

Because each gut microbiome is unique, shaped by genetics, environment, diet history, and antibiotic exposure, responses to dietary and lifestyle interventions can vary. Individualised assessment through tools such as shotgun metagenomic sequencing may help determine whether targeted strategies are appropriate and which interventions are most relevant.

Functional Medicine Perspective

Akkermansia muciniphila is best considered within the broader context of gut ecology rather than in isolation. Comprehensive stool testing, such as advanced microbiome analysis using detailed microbiome profiling, can help identify patterns that may be influencing Akkermansia abundance and gut function overall.

In some cases, metabolic assessment tools like organic acid testing may provide additional insight into microbial-metabolic interactions when symptoms suggest broader biochemical involvement.

Integrating advanced testing with personalised nutrition, targeted supplementation where appropriate, and sustainable lifestyle strategies allows for a more comprehensive and individualised approach to gut health optimisation.

Frequently Asked Questions

What is Akkermansia muciniphila?
Akkermansia muciniphila is a beneficial gut bacterium that lives in the intestinal mucus layer and helps support gut barrier integrity, mucus renewal, and inflammation regulation. It was first isolated by Muriel Derrien and Professor Willem de Vos at Wageningen University in 2004.

Is Akkermansia muciniphila linked to metabolic health?
Higher levels of Akkermansia muciniphila have been associated with healthier metabolic markers in human studies, and a 2019 clinical trial published in Nature Medicine by Professor Patrice Cani’s research group found pasteurised Akkermansia improved insulin sensitivity.

How can Akkermansia muciniphila be supported naturally?
Akkermansia muciniphila may be supported through a diverse, fibre-rich diet including polyphenol-containing foods such as cranberries and pomegranate, and regular physical activity, with individual responses varying based on baseline microbiome composition.

Key Insights

  • Akkermansia muciniphila is associated with gut barrier integrity, inflammation regulation, and metabolic health
  • Its relationship with the intestinal mucus layer appears central to its benefits, based largely on mouse studies
  • The outer membrane protein Amuc_1100 may modulate immune responses through TLR2 signalling
  • Diet, lifestyle, and individual gut patterns all influence Akkermansia levels
  • Personalised, test-guided approaches may offer greater clinical relevance than generic strategies

Citable Takeaways

  1. Akkermansia muciniphila makes up about 0.5-5% of total gut bacteria and is one of the most abundant single species in the human gut, according to a 2017 review by Cani and de Vos.
  2. A 2019 proof-of-concept trial by Depommier, Cani and colleagues, published in Nature Medicine, found that pasteurised Akkermansia improved insulin sensitivity by about 29% and lowered total cholesterol by about 9% compared with placebo in overweight and obese insulin-resistant volunteers.
  3. The Akkermansia outer membrane protein Amuc_1100 interacts with Toll-like receptor 2 (TLR2) and, in lab studies, mainly drove production of the anti-inflammatory cytokine IL-10.
  4. Cranberry and grape polyphenols raised Akkermansia in mouse studies, and a 2019 systematic review of human trials reported increases with pomegranate extract and resveratrol.
  5. Lower Akkermansia levels have been reported in people with overweight, obesity, untreated type 2 diabetes, and inflammatory bowel disease.
  6. Akkermansia secretes a protein called P9 that triggered GLP-1 secretion and improved glucose control in mice.

Optimise Your Gut Health From the Inside Out

Understanding your unique gut ecology is the first step toward targeted support. At Elemental Health and Nutrition, we use advanced microbiome testing and personalised nutrition strategies to help you support beneficial bacteria like Akkermansia and improve overall gut and metabolic health.

Book an Appointment

References

  1. Derrien M et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(Pt 5):1469-1476. https://doi.org/10.1099/ijs.0.02873-0
  2. Cani PD, de Vos WM. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. https://doi.org/10.3389/fmicb.2017.01765
  3. Depommier C et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. https://doi.org/10.1038/s41591-019-0495-2
  4. Dao MC et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65(3):426-436. https://doi.org/10.1136/gutjnl-2014-308778
  5. Everard A et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066-9071. https://doi.org/10.1073/pnas.1219451110
  6. Ottman N et al. Genome-Scale Model and Omics Analysis of Metabolic Capacities of Akkermansia muciniphila Reveal a Preferential Mucin-Degrading Lifestyle. Appl Environ Microbiol. 2017;83(18):e01014-17. https://doi.org/10.1128/AEM.01014-17
  7. Bian X et al. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Microbiol. 2019;10:2259. https://doi.org/10.3389/fmicb.2019.02259
  8. Plovier H et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107-113. https://doi.org/10.1038/nm.4236
  9. Ottman N et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One. 2017;12(3):e0173004. https://doi.org/10.1371/journal.pone.0173004
  10. Reunanen J et al. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol. 2015;81(11):3655-3662. https://doi.org/10.1128/AEM.04050-14
  11. Chelakkot C et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018;50(2):e450. https://doi.org/10.1038/emm.2017.282
  12. Yoon HS et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563-573. https://doi.org/10.1038/s41564-021-00880-5
  13. Dao MC et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement. Am J Physiol Endocrinol Metab. 2019;317(3):E446-E459. https://doi.org/10.1152/ajpendo.00140.2019
  14. Zhang X et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8(8):e71108. https://doi.org/10.1371/journal.pone.0071108
  15. de la Cuesta-Zuluaga J et al. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 2017;40(1):54-62. https://doi.org/10.2337/dc16-1324
  16. Png CW et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420-2428. https://doi.org/10.1038/ajg.2010.281
  17. Verhoog S et al. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review. Nutrients. 2019;11(7):1565. https://doi.org/10.3390/nu11071565
  18. Anhê FF et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872-883. https://doi.org/10.1136/gutjnl-2014-307142
  19. Roopchand DE et al. Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes. 2015;64(8):2847-2858. https://doi.org/10.2337/db14-1916
  20. Li J et al. Tea polyphenols regulate gut microbiota dysbiosis induced by antibiotic in mice. Food Res Int. 2021;141:110153. https://doi.org/10.1016/j.foodres.2021.110153
  21. Wastyk HC et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14. https://doi.org/10.1016/j.cell.2021.06.019
  22. Caesar R et al. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab. 2015;22(4):658-668. https://doi.org/10.1016/j.cmet.2015.07.026
  23. Bressa C et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One. 2017;12(2):e0171352. https://doi.org/10.1371/journal.pone.0171352

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts